DexCom (DXCM) PT Lowered to $520 at Stifel Following Q1 Report, but "Buy" Rating Maintained, "Bulk of The Headwinds are Transient in Nature"
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 82.97 -1.79 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.76 | 52 Week High | $96.38 | |||
| Open | $84.55 | 52 Week Low | $47.92 | |||
| Day High | $85.18 | P/E | N/A | |||
| Day Low | $82.81 | EPS | $-0.42 | |||
| Volume | 4,120,271 | |||||
